Last reviewed · How we verify
NCT06209541
Internet-based Cognitive Behavioral Therapy: a Factorial Randomized Controlled Trial About Treatment Content and Support
NA trial testing Internet-based cognitive behavioral therapy (ICBT) in Depression Symptoms in 176 participants. Participants enrolled and being followed up; not accepting new ones.
8 April 2024
Quick facts
| Lead sponsor | Linkoeping University |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 176 |
| Start date | 8 January 2024 |
| Primary completion | 8 April 2024 |
| Estimated completion | 30 April 2026 |
| Sites | 2 locations across Sweden |
Drugs / interventions tested
- Internet-based cognitive behavioral therapy (ICBT)
Conditions studied
- Depression Symptoms — all drugs for Depression Symptoms →
- Anxiety Symptoms — all drugs for Anxiety Symptoms →
Sponsor
Linkoeping University
Who can join
18 and older, any sex, with Depression Symptoms or Anxiety Symptoms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to investigate the differences in treatment outcomes between individually tailored and transdiagnostic internet-based cognitive behavioral therapy (ICBT), as well as the differences between weekly support by a specific therapist and weekly support by a team. The target group is adults (18 years or older) who experience mild to moderate depression symptoms, anxiety, stress or other psychological symptoms. The ICBT, in both types of treatment contents, consists of modules that the participants will work with for eight weeks in total. Participants will be recruited in Sweden with nationwide recruitment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06209541
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depression Symptoms
Currently open trials in the same condition.
- NCT07466979 — Exer-WAPA Project: Physical Exercise on Women's Affective and Physical HeAlth · NA · active not recruiting
- NCT06773338 — The Impact of Playing Tetris on Migrants' Mental Health · NA · recruiting
- NCT07208851 — Developing a Booster Session for Problem Management Plus in the Bahamas: A Pilot Randomized Controlled Trial · NA · recruiting
- NCT06707636 — Using Life's Essential 8 in Midlife Black Women · NA · active not recruiting
- NCT05589337 — Baduanjin Training for Depression and Anxiety Patients · NA · recruiting
Other Linkoeping University trials
Trials by the same sponsor.
- NCT07494422 — A Path to Prevention of Elder Abuse in Long-term Care. Prevalence Study Among Staff in Long-term Care. · not yet recruiting
- NCT07485439 — Self-inspired & Tailored Autism Movement With Phystic App · NA · enrolling by invitation
- NCT07391540 — ICBT for Psychological Symptoms Related to Economy · NA · recruiting
- NCT07181213 — Genetic Predisposition to High Blood Pressure · NA · enrolling by invitation
- NCT07312136 — MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06209541 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Linkoeping University
- Last refreshed: 9 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06209541.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing